FEDERATED HERMES, INC.

Position in AQST — Aquestive Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA

Position in AQST

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$12,948,253

+$745,847 QoQ

Shares Held

3,112,561

+5.9% QoQ

Ownership

2.48%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

of 185 holders

Holding Since

Sep 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $277,187,959 across 31 Drug Manufacturers - Specialty & Generic names. AQST ranks #5 (4.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LQDA	Liquidia Corp	816,187	$65,074,589
2	INDV	Indivior Pharmaceuticals, Inc.	1,468,749	$60,262,769
3	ELAN	Elanco Animal Health Inc	1,543,944	$37,996,460
4	IRWD	Ironwood Pharmaceuticals Inc	3,231,238	$13,603,511
5	AQST	Aquestive Therapeutics, Inc. This page	3,112,561	$12,948,253
6	NBIX	Neurocrine Biosciences Inc	76,569	$12,904,938
7	ALKS	Alkermes plc.	221,589	$11,611,263
8	XERS	Xeris Biopharma Holdings, Inc.	1,434,433	$11,360,709

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,948,253	3,112,561	+5.9%	Shares	Defined	2026-08-12
2026-03-31	$12,202,406	2,940,339	+44.6%	Shares	Defined	2026-05-11
2025-12-31	$13,132,030	2,032,822	+159.4%	Shares	Defined	2026-02-12
2025-09-30	$4,381,318	783,778	+55724.6%	Shares	Defined	2025-11-03
2024-03-31	$5,981	1,404	-42.7%	Shares	Defined	2024-05-14
2023-12-31	$4,946	2,449	+9.1%	Shares	Defined	2024-01-31
2023-09-30	$3,434	2,245	0.0%	Shares	Defined	2023-11-13
2023-06-30	$3,704	2,245	+3770.7%	Shares	Defined	2023-08-14
2020-09-30	$281	58	—	Shares	Defined	2020-11-12
No filing history on record for this holder in this stock.